Detalhe da pesquisa
1.
Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer.
Int J Mol Sci
; 23(18)2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36142299